Food and Drug Administration (FDA) has approved the first GLP-1 weight-loss pill, a tablet formulation of semaglutide
Here are the ones that fit the bill so far: Semaglutide: For weight loss, 2.4 mg of semaglutide (compared with 1 mg for diabetes management) is typically administered once weekly
Significant weight loss may leave patients with stretched, sagging skin, especially in the abdomen Significant weight loss, which is attainable with these effective prescriptions, may lead to loose or sagging skin as the skin loses elasticity and doesnt shrink back completely
If significant declines are observed, doses should be adjusted
Timing depends on the new medication and your health goals
Conversely, other studies 81,82 reported a 1.4%2.1% decrease in lumbar aBMD at 12 months, and Maghrabi et al